Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial
[RSS: feeds.arstechnica.com] The interim Phase I trial data was only from 35 people, but results look good so far.
Vercel's Shocking Eve Launch Finally Makes AI Agents Production-Ready This sound card could give gamers a competitive edge Waymo to begin passenger rides in its new Ojai robotaxi The secret to Roku’s success: not being cool Call of Duty: Modern Warfare 4 is out in October, and it’s coming to the Switch 2
Latest news regarding Health
[RSS: feeds.arstechnica.com] The interim Phase I trial data was only from 35 people, but results look good so far.
[RSS: feeds.arstechnica.com] Trump official asked CDC staff to volunteer to screen travelers at airports.
The blockbuster weight-loss drugs Ozempic and Wegovy are doing more than just shrinking waistlines; they're sparking seismic shifts across healthcare, food, and fashion.